Collaborating researchers at the University of North Carolina and Vanderbilt University have found that accelerating the rate of mutations in the coronavirus responsible for deadly severe acute respiratory syndrome (SARS) cripples the virus’s ability to cause disease in animals.

There are many reasons why David Shaffer, M.D., surgical director of the Kidney Transplantation Program at Vanderbilt University Medical Center, loves his job.

Researchers from the Monroe Carell Jr. Children’s Hospital at Vanderbilt and Aminu Kano Teaching Hospital in Kano, Nigeria, will work on a collaborative project to study a sickle cell disease treatment for children in Nigeria.

New findings from Vanderbilt researchers may explain why only some individuals who have inherited mutations that increase risk for pulmonary hypertension actually develop the disease.

Vanderbilt is taking part in a national study to test in older adults the use of a vaccine designed to protect children against a common cause of pneumonia.

Despite studies that show that many adolescents and young adults with autism spectrum disorders are being prescribed medications, there is almost no evidence to show whether these medications are helpful in this population.